Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Redox Report : Communications in Free Radical Research|April 16, 2020
Mitochondrial complex II and reactive oxygen species in disease and therapyKaterina Hadrava Vanova, Michal Kraus, Jiri Neuzil, et al.
Cancers|August 7, 2021
Reactive Oxygen Species: A Promising Therapeutic Target for <i>SDHx</i>-Mutated Pheochromocytoma and ParagangliomaKaterina Hadrava Vanova, Chunzhang Yang, Leah Meuter, et al.
Endocrine Reviews|February 20, 2024
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and PerspectivesOndrej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Frontiers in Endocrinology|June 21, 2023
Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacyOndrej Uher, Katerina Hadrava Vanova, Radka Lencova, et al.
Frontiers in Oncology|November 28, 2022
PD-L1 expression and association with genetic background in pheochromocytoma and paragangliomaKaterina Hadrava Vanova, Ondrej Uher, Leah Meuter, et al.
Trends in Molecular Medicine|August 6, 2025
Block, expose, and immunize: triple attack on cancerKaterina Hönigova, Katerina Hadrava Vanova, Martina Raudenska, et al.
Frontiers in Immunology|January 24, 2025
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancerMarketa Skalickova, Katerina Hadrava Vanova, Ondrej Uher, et al.
Cancer Letters|January 14, 2025
Neoadjuvant intratumoral MBT(A) immunotherapy prevents distant metastases and recurrence in murine modelsOndrej Uher, Katerina Hadrava Vanova, Rachael Labitt, et al.
Cancer Biology & Therapy|June 19, 2026
Opsonization and timing as key determinants of MBTA immunotherapy efficacy in pancreatic adenocarcinoma and recurrence treatmentAndrea Frejlachova, Radka Lencova, Ondrej Uher, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2024
Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma modelOndrej Uher, Katerina Hadrava Vanova, Katerina Petrlakova, et al.
Pageof 2